American Shared Hospital Services (NYSEAMERICAN:AMS) Earns Hold Rating from Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research note issued on Monday. The firm set a “hold” rating on the stock.

American Shared Hospital Services Stock Up 3.8 %

NYSEAMERICAN:AMS opened at $3.29 on Monday. American Shared Hospital Services has a twelve month low of $2.16 and a twelve month high of $3.69. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.98 and a quick ratio of 1.98. The company has a market cap of $20.83 million, a price-to-earnings ratio of 41.13 and a beta of 0.70.

American Shared Hospital Services (NYSEAMERICAN:AMS) last announced its quarterly earnings data on Tuesday, May 14th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). American Shared Hospital Services had a return on equity of 4.29% and a net margin of 2.50%. The company had revenue of $5.22 million for the quarter, compared to the consensus estimate of $5.01 million. On average, research analysts expect that American Shared Hospital Services will post 0.29 EPS for the current year.

Institutional Investors Weigh In On American Shared Hospital Services

A hedge fund recently bought a new stake in American Shared Hospital Services stock. Empowered Funds LLC purchased a new stake in American Shared Hospital Services (NYSEAMERICAN:AMS) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned 0.17% of American Shared Hospital Services at the end of the most recent quarter. 23.16% of the stock is owned by institutional investors.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.